Aimei Health Technology Co., Ltd (AFJK)
Oxford Ledge is still expanding full research coverage of AFJK. A delayed quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
Blank check company seeking to acquire small-cap businesses in biopharmaceutical, medical technology, and diagnostic services sectors.
Source: 10-K (2025-12-31) · AI-generated analysis. Not investment advice. May contain errors.
SEC filings
- 8-K Termination of material agreement; Regulation FD disclosure; Financial statements and exhibits 2026-07-08
- 8-K Creation of direct financial obligation; Financial statements and exhibits 2026-07-06
- 8-K Departure/election of directors or officers; Financial statements and exhibits 2026-06-29
- 10-Q Quarterly financial report (unaudited) 2026-06-16
- 8-K Creation of direct financial obligation; Financial statements and exhibits 2026-06-04
Source: SEC EDGAR.
Annual results
2 years of annual figures for AFJK, as filed with the SEC. Figures are as reported and are not restated or adjusted.
| Fiscal year | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| 2025 | — | $1.1M | — |
| 2024 | — | $2.6M | — |
Source: SEC EDGAR (XBRL company facts). Full statements and ratios in the terminal.
Insider activity
3 recent insider (SEC Form 4) filings on record for AFJK. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open AFJK in the Oxford Ledge terminal — delayed quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.